These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9836470)
21. [A case of papillary adenocarcinoma of the ovary that responded favorably to irinotecan hydrochloride and cisplatin after the administration of paclitaxel and carboplatin]. Shimoya K; Kunishige I; Okuno Y; Hayashi S; Komura H; Arimoto Y; Otsuki Y Gan To Kagaku Ryoho; 2001 Jun; 28(6):845-8. PubMed ID: 11432356 [TBL] [Abstract][Full Text] [Related]
22. Intraperitoneal therapy for ovarian cancer: why has it not become standard? Rowan K J Natl Cancer Inst; 2009 Jun; 101(11):775-7. PubMed ID: 19470952 [No Abstract] [Full Text] [Related]
24. [Recent advances in ovarian cancer chemotherapy from the survival standpoint]. Hatae M; Onishi Y; Maeda Y; Maeda T; Hirano T; Kamitomo M Gan To Kagaku Ryoho; 1995 May; 22(6):718-25. PubMed ID: 7755379 [TBL] [Abstract][Full Text] [Related]
25. Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancer. Ozols RF Semin Oncol; 1995 Dec; 22(6 Suppl 15):1-6. PubMed ID: 8643963 [TBL] [Abstract][Full Text] [Related]
32. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie. du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Bauknecht T; Warm M; Schroeder W; Olbricht S; Nitz U; Jackisch C Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296 [TBL] [Abstract][Full Text] [Related]
33. Current clinical practices for ovarian cancers. Harper P Semin Oncol; 2002 Jun; 29(3 Suppl 8):3-6. PubMed ID: 12082646 [TBL] [Abstract][Full Text] [Related]
34. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222 [TBL] [Abstract][Full Text] [Related]
36. [Current status and prospects of chemotherapy of ovarian cancer]. Sen K; Lang JH; Lian LJ Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):753-7. PubMed ID: 7712905 [No Abstract] [Full Text] [Related]
37. Confirmation of the "old" standard of care for ovarian cancer and a challenge. McGuire WP J Natl Cancer Inst; 2000 May; 92(9):674-5. PubMed ID: 10793094 [No Abstract] [Full Text] [Related]
38. Chemotherapy for ovarian cancer. Lacave AJ; Peláez I; Palacio I N Engl J Med; 1996 May; 334(19):1269-70. PubMed ID: 8606731 [No Abstract] [Full Text] [Related]
39. Intraperitoneal therapy for advanced ovarian cancer: will it become standard care? Bankhead C J Natl Cancer Inst; 2006 Apr; 98(8):510-2. PubMed ID: 16622116 [No Abstract] [Full Text] [Related]
40. [Application of ATP-tumor chemosensitivity assay in primary epithelial ovarian cancer]. Zhao D; Wu LY; Wang XB; Li XG; Li M; Li YF; Tian HM; Zhang W Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):368-72. PubMed ID: 20723436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]